EASL mourns the passing of Professor Stephanos J Hadziyannis, who died peacefully on Monday 17 November. His loss is deeply felt across the hepatology community, where he was regarded as a visionary clinician scientist and one of the most influential…
NEWS RELEASE UNDER EMBARGO UNTIL OCTOBER 27, 2025, 00:01 ET (12:01 AM ET) Media contact: Freya Weise, MD, PhD Elsevier +33 (1) 71 16 55 00 hmsmedia@elsevier.com
New publication calls for liver health to be fully recognised within the global NCD agenda A new publication by Aleksander Krag (Odense University Hospital, Denmark), Francesco Negro (University Hospital of Geneva, Switzerland), and Debbie L. Shawcross (King’s College London, United…
The EASL Guidelines Dissemination Programme is a new core component of EASL's educational strategy designed to advance liver care through the adoption of Clinical Practice Guidelines (CPGs). Since 2009, EASL has published CPGs covering all major areas of hepatology. However, despite…
NEWS RELEASE UNDER EMBARGO UNTIL OCTOBER 9, 2025, 12:01 AM ET Media contact: Freya Weise, MD, PhD Elsevier +33 (1) 71 16 55 00 hmsmedia@elsevier.com
We are excited to announce the launch of the call for nominations and applications for three prestigious awards: the EASL Community Award 2026, the EASL Emerging Leader Award 2026, and the EASL Excellence in Liver Care Award 2026. These awards…
PRESS RELEASE FOR IMMEDIATE RELEASE 15 September 2025 The EU is on the brink of authorising wines with up to 6% alcohol by volume to be labelled as “low-alcohol.” The European Health Alliance on Alcohol (EHAA) – representing more than…
NEWS RELEASE UNDER EMBARGO UNTIL AUGUST 27, 2025, 12:01 AM ET Media contact: Freya Weise, MD, PhD Elsevier +33 (1) 71 16 55 00 hmsmedia@elsevier.com
EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative…
This paper is more than a review: it is a consensus report by a group of 34 leading international experts in hepatology, data science, and artificial intelligence, presenting concrete recommendations for the clinical application of AI in hepatology.